Betahydroxybutyrate Consumption in Autopsy Brain Tissue from Alzheimer’s Disease Subjects

BACKGROUND: Alzheimer’s disease (AD) features perturbed brain glucose utilization, which could contribute to brain bioenergetic failure. This led some to consider using ketone bodies to enhance AD brain bioenergetics and treat AD. OBJECTIVE: We evaluated the rate at which brain homogenates from pers...

Descripción completa

Detalles Bibliográficos
Autores principales: Swerdlow, Russell H., de Leon, Mony J., Marcus, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990458/
https://www.ncbi.nlm.nih.gov/pubmed/33782666
http://dx.doi.org/10.3233/ADR-210002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990458/
https://www.ncbi.nlm.nih.gov/pubmed/33782666
http://dx.doi.org/10.3233/ADR-210002

Ejemplares similares